Heading ImageBrowse Florida Hospital Research
Image
Florida Hospital
Image

Florida Hospital is committed to developing new medical devices and treatments through a disciplined approach of understanding the underlying causes of human disease. Finding tomorrow’s breakthrough medical treatments and advancements starts with today’s research. Our research has been recognized and published in renowned peer-reviewed publications such as The Journal of the American Medical Association, The Journal of Thoracic and Cardiovascular Surgery, and Contemporary Clinical Trials (Elsevier).

We oversee dozens of research studies every year across many clinical disciplines. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. Please use the search field below to search for studies they have made accessible and filtered for Florida Hospital. For additional search filters and options, please visit ClinicalTrials.gov.


136 results found

GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent Ovarian Cancer
Status: Recruiting
Last Changed: June 1, 2017
Conditions: Ovarian Cancer; Peritoneal Carcinomatosis; Fallopian Tube Cancer
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer
Status: Recruiting
Last Changed: June 16, 2017
Conditions: Cancer of Ovary; Neoplasms, Ovarian; Ovarian Cancer Stage IV; Ovarian Cancer Recurrent; Ovarian Cancer Stage III; Ovary Cancer
Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
Status: Recruiting
Last Changed: March 15, 2017
Conditions: Hypoxic Ischemic Encephalopathy
Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
Status: Recruiting
Last Changed: March 21, 2017
Conditions: Bronchopulmonary Dysplasia (BPD)
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
Status: Recruiting
Last Changed: June 30, 2017
Conditions: Heart Failure; Respiratory Insufficiency; Stroke Acute; Infectious Diseases; Rheumatic Diseases
Methadone Demonstration Project
Status: Recruiting
Last Changed: April 26, 2017
Conditions: Neonatal Abstinence Syndrome
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Stage IB Non-Small Cell Lung Carcinoma AJCC v7; Stage IIA Non-Small Cell Lung Carcinoma AJCC v7; Stage IIB Non-Small Cell Lung Carcinoma AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Recruiting
Last Changed: July 26, 2017
Conditions: BRAF V600E Mutation Present; BRAF V600K Mutation Present; Recurrent Melanoma; Stage III Skin Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Acinar Cell Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Dermoid Cyst; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metastatic Malignant Neoplasm of Unknown Primary Origin; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Placental-Site Gestational Trophoblastic Tumor; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Malignant Transformation; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Undifferentiated Gastric Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Adenocarcinoma; Vulvar Squamous Cell Carcinoma
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Colorectal Cancer
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Status: Recruiting
Last Changed: July 12, 2017
Conditions: Breast Cancer
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Lung Cancer
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Recruiting
Last Changed: March 8, 2016
Conditions: Stage IB Non-Small Cell Lung Carcinoma; Stage IIA Non-Small Cell Lung Carcinoma; Stage IIB Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Stage II Breast Cancer; Stage IIIA Breast Cancer
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Status: Recruiting
Last Changed: May 2, 2017
Conditions: Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Stage IA Cervical Cancer; Stage IB Cervical Cancer; Stage IIA Cervical Cancer
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Status: Recruiting
Last Changed: May 2, 2017
Conditions: Stage I Uterine Sarcoma; Uterine Corpus Leiomyosarcoma
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
Status: Recruiting
Last Changed: July 10, 2017
Conditions: Peripheral Artery Disease; Atherosclerosis; Artery Diseases, Peripheral; Plaque, Atherosclerotic; Occlusive Arterial Disease
A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
Status: Recruiting
Last Changed: July 20, 2017
Conditions: Carcinoma, Non-Small-Cell Lung
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Fatigue
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Status: Recruiting
Last Changed: June 30, 2017
Conditions: Neoplasms
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Status: Recruiting
Last Changed: June 30, 2017
Conditions: Heart Failure; Coronary Artery Disease
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
Status: Recruiting
Last Changed: April 20, 2017
Conditions: Infusion Reactions
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Recruiting
Last Changed: July 19, 2017
Conditions: Pulmonary Hypertension; Interstitial Lung Disease; Combined Pulmonary Fibrosis and Emphysema
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Status: Recruiting
Last Changed: July 24, 2017
Conditions: Adult Fibrosarcoma; Alveolar Soft Part Sarcoma; Angiomatoid Fibrous Histiocytoma; Atypical Fibroxanthoma; Clear Cell Sarcoma of Soft Tissue; Epithelioid Malignant Peripheral Nerve Sheath Tumor; Epithelioid Sarcoma; Extraskeletal Myxoid Chondrosarcoma; Extraskeletal Osteosarcoma; Fibrohistiocytic Neoplasm; Glomus Tumor of the Skin; Inflammatory Myofibroblastic Tumor; Intimal Sarcoma; Leiomyosarcoma; Liposarcoma; Low Grade Fibromyxoid Sarcoma; Low Grade Myofibroblastic Sarcoma; Malignant Cutaneous Granular Cell Tumor; Malignant Peripheral Nerve Sheath Tumor; Malignant Triton Tumor; Mesenchymal Chondrosarcoma; Myxofibrosarcoma; Myxoid Chondrosarcoma; Myxoinflammatory Fibroblastic Sarcoma; Nerve Sheath Neoplasm; PEComa; Pericytic Neoplasm; Plexiform Fibrohistiocytic Tumor; Sclerosing Epithelioid Fibrosarcoma; Stage IB Soft Tissue Sarcoma; Stage IIB Soft Tissue Sarcoma; Stage III Soft Tissue Sarcoma; Stage IV Soft Tissue Sarcoma; Synovial Sarcoma; Undifferentiated (Embryonal) Sarcoma; Undifferentiated High Grade Pleomorphic Sarcoma of Bone
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)
Status: Recruiting
Last Changed: February 7, 2017
Conditions: Multiple Myeloma
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Status: Recruiting
Last Changed: September 16, 2014
Conditions: Breast Cancer
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Recruiting
Last Changed: July 11, 2017
Conditions: Crohn Disease
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Status: Recruiting
Last Changed: July 10, 2017
Conditions: Non-Small Cell Lung Cancer
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Status: Recruiting
Last Changed: July 24, 2017
Conditions: Pancreatic Cancer
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Status: Recruiting
Last Changed: May 23, 2017
Conditions: Prostate Cancer
The PARTNER 3 - Trial - The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
Status: Recruiting
Last Changed: July 24, 2017
Conditions: Aortic Stenosis
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Status: Recruiting
Last Changed: July 3, 2017
Conditions: Small Cell Lung Carcinoma
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraductal Papillary-Mucinous Neoplasm; Stage IA Pancreatic Cancer AJCC v6 and v7; Stage IB Pancreatic Cancer AJCC v6 and v7; Stage IIA Pancreatic Cancer AJCC v6 and v7; Stage IIB Pancreatic Cancer AJCC v6 and v7
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Status: Recruiting
Last Changed: July 17, 2017
Conditions: PRETEXT Stage 1 Hepatoblastoma; PRETEXT Stage 2 Hepatoblastoma; PRETEXT Stage 3 Hepatoblastoma; PRETEXT Stage 4 Hepatoblastoma
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Status: Recruiting
Last Changed: July 17, 2017
Conditions: Classical Hodgkin Lymphoma; Stage IIB Hodgkin Lymphoma; Stage IIIB Hodgkin Lymphoma; Stage IVA Hodgkin Lymphoma; Stage IVB Hodgkin Lymphoma
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Status: Recruiting
Last Changed: July 17, 2017
Conditions: B Acute Lymphoblastic Leukemia; Bone Necrosis; Central Nervous System Leukemia; Cognitive Side Effects of Cancer Therapy; Neurotoxicity Syndrome; Pain; Ph-Like Acute Lymphoblastic Leukemia; Testicular Leukemia; Therapy-Related Toxicity; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Status: Recruiting
Last Changed: July 17, 2017
Conditions: Adult T Acute Lymphoblastic Leukemia; Childhood T Acute Lymphoblastic Leukemia; Stage II Childhood Lymphoblastic Lymphoma; Stage II Contiguous Adult Lymphoblastic Lymphoma; Stage II Non-Contiguous Adult Lymphoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: July 21, 2017
Conditions: Leukemia Cutis; Myeloid Sarcoma; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Myeloid Neoplasm
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Metastatic Ewing Sarcoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Bone Marrow; Metastatic Malignant Neoplasm in the Lung; Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone; Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Recruiting
Last Changed: July 21, 2017
Conditions: B Acute Lymphoblastic Leukemia
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Status: Recruiting
Last Changed: July 21, 2017
Conditions: Acute Leukemia of Ambiguous Lineage; Childhood B Acute Lymphoblastic Leukemia; KMT2A Gene Rearrangement; Mixed Phenotype Acute Leukemia
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Status: Recruiting
Last Changed: June 29, 2016
Conditions: Non-Small Cell Lung Cancer
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Recruiting
Last Changed: April 3, 2017
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Recruiting
Last Changed: May 5, 2017
Conditions: Non Alcoholic Steatohepatitis (NASH)
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Status: Recruiting
Last Changed: May 2, 2017
Conditions: Endometrial Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Undifferentiated Carcinoma; Recurrent Uterine Corpus Carcinoma; Stage IIIA Uterine Corpus Cancer; Stage IIIB Uterine Corpus Cancer; Stage IIIC Uterine Corpus Cancer; Stage IVA Uterine Corpus Cancer; Stage IVB Uterine Corpus Cancer
A Study of Cobimetinib in Combination With Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, and Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as First-line Treatment for Participants With Metastatic Triple-Negative Breast Cancer
Status: Recruiting
Last Changed: June 26, 2017
Conditions: Breast Cancer
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Status: Recruiting
Last Changed: June 5, 2017
Conditions: Rectal Cancer; Anastomotic Leak
A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
Status: Recruiting
Last Changed: March 12, 2017
Conditions: Ischemic Stroke
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting
Status: Recruiting
Last Changed: July 25, 2017
Conditions: Multiple Myeloma
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Ductal Breast Carcinoma In Situ; Estrogen Receptor and/or Progesterone Receptor Positive; HER2/Neu Negative; Invasive Breast Carcinoma; Multicentric Breast Carcinoma; Multifocal Breast Carcinoma; Synchronous Bilateral Breast Carcinoma
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Recruiting
Last Changed: July 26, 2017
Conditions: Adrenal Cortex Carcinoma; Adult Alveolar Soft Part Sarcoma; Adult Clear Cell Sarcoma of Soft Parts; Adult Hepatocellular Carcinoma; Adult Rhabdomyosarcoma; Adult Soft Tissue Sarcoma; Childhood Alveolar Soft Part Sarcoma; Childhood Central Nervous System Neoplasm; Childhood Clear Cell Sarcoma of Soft Parts; Childhood Hepatocellular Carcinoma; Childhood Rhabdomyosarcoma; Childhood Soft Tissue Sarcoma; Childhood Solid Neoplasm; Ewing Sarcoma; Hepatoblastoma; Hepatocellular Carcinoma; Recurrent Adrenal Cortex Carcinoma; Recurrent Adult Hepatocellular Carcinoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Alveolar Soft Part Sarcoma; Recurrent Childhood Central Nervous System Neoplasm; Recurrent Childhood Hepatocellular Carcinoma; Recurrent Childhood Soft Tissue Sarcoma; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Malignant Solid Neoplasm; Recurrent Renal Cell Carcinoma; Recurrent Rhabdomyosarcoma; Renal Cell Carcinoma; Thyroid Gland Medullary Carcinoma; Wilms Tumor
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Status: Recruiting
Last Changed: August 30, 2016
Conditions: Childhood Infratentorial Ependymoma; Childhood Supratentorial Ependymoma; Newly Diagnosed Childhood Ependymoma
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
Status: Recruiting
Last Changed: June 6, 2017
Conditions: Non-alcoholic Steatohepatitis; Fibrosis; Liver Diseases
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Status: Recruiting
Last Changed: September 28, 2016
Conditions: Cervical Cancer
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Recruiting
Last Changed: May 2, 2017
Conditions: Glioblastoma; Gliosarcoma
A Study of Atezolizumab (MPDL3280A) as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Clinical Evaluation of Novel Blood-Based Diagnostics [B-F1RST]
Status: Recruiting
Last Changed: July 10, 2017
Conditions: Non-Small Cell Lung Cancer
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Status: Recruiting
Last Changed: December 4, 2012
Conditions: Brain and Central Nervous System Tumors; Neurotoxicity
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Recruiting
Last Changed: July 6, 2017
Conditions: Ovarian Cancer; Ovarian Neoplasm
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Status: Recruiting
Last Changed: September 23, 2016
Conditions: Adult B Lymphoblastic Lymphoma; Childhood B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1; Childhood B Lymphoblastic Lymphoma; Down Syndrome; Stage I B Lymphoblastic Lymphoma; Stage II B Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Status: Recruiting
Last Changed: August 19, 2016
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Pineoblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Status: Recruiting
Last Changed: August 18, 2016
Conditions: Childhood Acute Myeloid Leukemia; Childhood Myelodysplastic Syndrome; Cytopenia; Down Syndrome; Myeloid Leukemia Associated With Down Syndrome; Myeloproliferative Neoplasm
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Recruiting
Last Changed: June 29, 2017
Conditions: Neoplasms
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
Status: Recruiting
Last Changed: June 8, 2017
Conditions: Metastatic Breast Cancer
The PARTNER 3 - AVIV Trial
Status: Recruiting
Last Changed: July 24, 2017
Conditions: Aortic Stenosis; Cardiomyopathy, Hypertrophic
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Recruiting
Last Changed: September 16, 2014
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia
Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma
Status: Recruiting
Last Changed: July 20, 2017
Conditions: Multiple Myeloma
Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Status: Recruiting
Last Changed: May 16, 2017
Conditions: Gastroesophageal Cancer
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)
Status: Recruiting
Last Changed: July 18, 2017
Conditions: Autism
An Open Label Study of CM-AT for the Treatment of Children With Autism
Status: Recruiting
Last Changed: July 18, 2017
Conditions: Autism
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Recruiting
Last Changed: February 9, 2016
Conditions: Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube Mucinous Adenocarcinoma; Fallopian Tube Serous Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Malignant Ovarian Brenner Tumor; Malignant Ovarian Mixed Epithelial Tumor; Ovarian Clear Cell Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Adenocarcinoma; Ovarian Serous Adenocarcinoma; Ovarian Transitional Cell Carcinoma; Primary Peritoneal Serous Adenocarcinoma; Stage IIA Fallopian Tube Cancer; Stage IIA Ovarian Cancer; Stage IIB Fallopian Tube Cancer; Stage IIB Ovarian Cancer; Stage IIC Fallopian Tube Cancer; Stage IIC Ovarian Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Cancer; Stage IIIA Primary Peritoneal Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Cancer; Stage IIIB Primary Peritoneal Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Cancer; Stage IIIC Primary Peritoneal Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Cancer; Stage IV Primary Peritoneal Cancer; Undifferentiated Fallopian Tube Carcinoma; Undifferentiated Ovarian Carcinoma
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Recruiting
Last Changed: June 22, 2017
Conditions: Acute Graft-versus-host Disease
A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Patients With Kidney Transplant
Status: Recruiting
Last Changed: February 15, 2017
Conditions: Acute Antibody-Mediated Rejection (AMR)
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
Status: Recruiting
Last Changed: June 13, 2017
Conditions: Carcinoma, Non-small-Cell Lung
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Arthralgia; Breast Cancer; Hot Flashes; Musculoskeletal Complications; Sexual Dysfunction
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Status: Recruiting
Last Changed: May 18, 2017
Conditions: Head and Neck Cancer
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Status: Recruiting
Last Changed: June 14, 2017
Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Pancreatic Adenocarcinoma; Borderline Resectable Adenocarcinoma of the Head of the Pancrease
Effect of Armodafinil on Simulated Driving
Status: Recruiting
Last Changed: May 23, 2017
Conditions: Healthy Volunteers
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Status: Recruiting
Last Changed: June 12, 2017
Conditions: Veno-occlusive Disease
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
Status: Recruiting
Last Changed: September 12, 2016
Conditions: Post-ERCP Pancreatitis
Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
Status: Recruiting
Last Changed: October 6, 2016
Conditions: Pulmonary Hypertension
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Recruiting
Last Changed: June 26, 2017
Conditions: Brain and Central Nervous System Tumors
Breast Cancer WEight Loss Study (BWEL Study)
Status: Recruiting
Last Changed: June 20, 2017
Conditions: Breast Carcinoma
Double Cord Versus Haploidentical (BMT CTN 1101)
Status: Recruiting
Last Changed: February 7, 2017
Conditions: Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia; Burkitt's Lymphoma; Follicular Lymphoma; Hodgkin Lymphoma; Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
Status: Recruiting
Last Changed: October 22, 2014
Conditions: Lymphomas
Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
Status: Recruiting
Last Changed: June 5, 2017
Conditions: Recurrent Childhood Medulloblastoma; Recurrent Childhood Ependymoma; Childhood Atypical Teratoid/Rhabdoid Tumor; Embryonal Tumor With Abundant Neuropil and True Rosettes; Metastatic Malignant Neoplasm to the Leptomeninges
Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors
Status: Recruiting
Last Changed: February 8, 2017
Conditions: Central Nervous System Tumors
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
Status: Recruiting
Last Changed: June 21, 2017
Conditions: Leukemia; Acute Myelogenous Leukemia; Acute Myeloid Leukemia
Study Testing if Fast or Slow rTMS is Better for the Treatment of Posttraumatic Stress Disorder (PTSD)
Status: Recruiting
Last Changed: August 29, 2016
Conditions: Posttraumatic Stress Disorder; Depression
Ameliorating Work Burnout and Medical Residents
Status: Recruiting
Last Changed: April 12, 2016
Conditions: Burnout, Professional; Depression; Stress; Anxiety; Distress
Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams
Status: Recruiting
Last Changed: June 12, 2015
Conditions: Benign Prostatic Hyperplasia
Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis
Status: Recruiting
Last Changed: December 6, 2016
Conditions: Vitamin D Deficiency
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
Status: Recruiting
Last Changed: February 23, 2017
Conditions: Neuroblastoma; Neoplasms, Nerve Tissue
Rehabilitating Corticospinal Control of Walking
Status: Recruiting
Last Changed: April 19, 2017
Conditions: Stroke
Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Status: Recruiting
Last Changed: July 7, 2017
Conditions: Spinal Cord Injury; Spinal Cord Injuries; Trauma, Nervous System; Wounds and Injuries; Central Nervous System Diseases; Nervous System Diseases; Spinal Cord Diseases; Gonadal Disorders; Endocrine System Diseases; Hypogonadism; Genital Diseases, Male
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Status: Recruiting
Last Changed: April 25, 2017
Conditions: Rhabdomyosarcoma
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)
Status: Not yet recruiting
Last Changed: June 1, 2017
Conditions: Amyotrophic Lateral Sclerosis
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
Status: Recruiting
Last Changed: April 2, 2017
Conditions: Thoracoabdominal Aortic Aneurysm
Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Status: Recruiting
Last Changed: September 16, 2016
Conditions: Transient Ischemic Attack; Stroke; Atrial Fibrillation
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Status: Recruiting
Last Changed: April 12, 2017
Conditions: Kidney Cancer

Page: 1 of 7

Last Modified: 6/30/2016